title: An early indicator of drug success: Top Journal Selectivity Index.
abstract: The Top Journal Selectivity Index (TJSI) is a scientometric index reflecting the potential importance of a new drug. It represents the ratio of the number of all types of articles on a particular drug in the top 20 journals relative to the number of articles in all (>5,000) biomedical journals covered by Medline over the 5 years since the drug's introduction. The TJSI can be an indicator of a drug's potential for sustained use: a higher score increases the probability of continuing success.
authors: Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. kissin@zeus.bwh.harvard.edu
authors: Igor
authors: I
authors: Kissin
mesh_terms: D015706:Bibliometrics; D015195:Drug Design; D055808:Drug Discovery / Q000706:statistics & numerical data; D006801:Humans; D010506:Periodicals as Topic / Q000706:statistics & numerical data*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D004364:Pharmaceutical Preparations
keywords: bibliometrics; pharmaceutical market; scientometrics; ‘me-too’ drugs